Type I interferon gene signature test–low and –high patients with systemic lupus erythematosus have distinct gene expression signatures

Abstract excerpt

Objectives Type I interferon (IFN) is implicated in systemic lupus erythematosus (SLE) pathogenesis. We aimed to identify type I IFN signaling-dependent and -independent molecular pathways in a large population of patients with SLE. Methods Baseline blood samples from adult patients with moderate to severe SLE from two Phase IIb studies (NCT01438489, n = 265; NCT01283139, n = 416) were profiled using whole...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Inflammatory Myopathies and Dermatomyositis
• Share to Systemic Lupus Erythematosus Research
• Share to Systemic Sclerosis and Related Diseases